
CMC Considerations From Development Through Registration of An Autologous CAR-T Therapy

Speaker Presentation Gillet Delphine, Novartis Pharma AG, 2021
CMC Considerations From Development Through Registration of An Autologous CAR-T Therapy
Speaker Presentation Gillet Delphine, Novartis Pharma AG, 2021
CMC Considerations From Development Through Registration of An Autologous CAR-T Therapy